TheGridNet
The Melbourne Grid Melbourne

Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis

MELBOURNE, Australia, Oct. 23, 2023 /PRNewswire/ -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the U.S. Food

Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis

Veröffentlicht : vor 2 Jahren durch PR Newswire in Business Health

(BPT) - When it comes to diet, there seems to be a constant stream of extreme, contradictory advice out there. A news report may say one kind of food is “deadly,” while superfoods are promoted by social media influencers. The result: If you’re concerned about health, you may be sacrificing f…


Themen: FDA

Read at original source